WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Brain Tumor efficacy endpoints v1, New lesion identified by Organ specific lesion ID, Performance Status Rating measured by Karnofsky, Non-measurable lesions has subtype Non-target lesion, Concepts are denoted by solid round-edged rectangle, Target lesion evaluated by Quantitative assessment, Tumor Response is assessed with -MRI -CT -PET/CT -Chest X-ray (CXR) -Bone scan -Other, Disease characteristics include Mutation, New lesion identified by Anatomical region, - PD associated with Date of tumor progression, COVARIATES include Disease characteristics, Intensity score instantiated by 0, 1, 2, ..., -Complete Response (CR) -Non-CR/non-PD -Not all evaluated -Non-PD -PD summarized into OVERALL RESPONSE, Prior Therapy include Systemic, Ethnicity include - Hispanic or Latino - Not Hispanic or Latino - Other, Mutation has attributes Mutation type, Measurable lesions has subtype Target lesion, CNS response or CNS PFS assesses Disease Progression, % Staining instantiated by 1 - 100%, PRIMARY BRAIN TUMOR Assessment ???? McDonald Criteria, SCLC classified as - Limited-Stage Disease - Extensive-Stage Disease